{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:17:09Z","timestamp":1790957829463,"version":"4.1.0"},"reference-count":50,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Res (Stuttg)"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background Tuberculosis (TB) caused by Mycobacterium tuberculosis is one of the main killers of people all over the world. The major hurdles with existing therapy are the lengthy regimen and appearance of multi drug resistant (MDR) and extensively drug resistant (XDR) strains of M.tuberculosis.<\/jats:p>\n                  <jats:p>Aims The present work was aimed to synthesize and determine antitubercular and antimicrobial potential of some novel 3-chloro-4-aryl-1-[4-(5-pyrazin-2-yl[1,3,4]oxadiazole-2-ylmethoxy)-phenyl]-azetidin-2-one derivatives 7(a-h) from pyrazinoic acid as precursor, which is a well-established antitubercular agent. Here we report the synthesis of a new class of heterocyclic molecules in which pyrazine, 1, 3, 4-oxadiazole and azetidinone moieties were present in one frame work.<\/jats:p>\n                  <jats:p>Methods Pyrazinoic acid (1) was esterified first (2) followed by amination to produce hydrazide (3) which was refluxed with POCl3 to obtain 2-chloromethyl-5pyrazino-1, 3, 4-oxadiazole (4). This was then further reacted with 4-amino phenol to obtain 4-[5-pyrazino-1, 3, 4-oxadiazol-2-yl-methoxy]-phenyl amine (5) which on condensation with various aromatic aldehydes afforded a series Schiff\u2019s bases 6(a-h). Dehydrative annulations of 6(a-h) in the presence of chloroacetyl chloride and triethylamine yielded 3-chloro-4-aryl-1-[4-(5-pyrazin-2-yl-[1, 3, 4]oxadiazole-2-ylmethoxy)-phenyl]-azetidin-2-one derivatives 7(a-h). Antibacterial, antifungal and antitubercular potential of all the synthesized compounds were assessed. Docking study was performed using the software VLife Engine tools of Vlifemds 4.6 on the protein lumazine synthase of M. tuberculosis (PDB entry code 2C92).<\/jats:p>\n                  <jats:p>Results The present studies demonstrated that synthesized oxadiazole derivatives have good antimicrobial activity against the various microorganisms. Among the synthesized derivative, 7b and 7g were found to be prominent compounds which have potential antibacterial, antifungal and antitubercular activity (with MIC 3.12\u2009\u00b5g\/ml and high dock score ranging from \u221259.0 to \u221254.0) against Mycobacterium tuberculosis.<\/jats:p>\n                  <jats:p>Conclusions Derivatives 7b and 7g would be effective lead candidates for tuberculosis therapy.<\/jats:p>","DOI":"10.1055\/a-1252-2378","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T19:03:22Z","timestamp":1602097402000},"page":"26-35","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular"],"prefix":"10.1055","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-2729","authenticated-orcid":false,"given":"Rina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.trstmh.2008.08.004","article-title":"Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria","volume":"103","author":"A E Ani","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijid.2008.10.006","article-title":"Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis","volume":"13","author":"H A Said","year":"2009","journal-title":"Int J Infect Dis"},{"key":"ref3","first-page":"19","article-title":"Synthesis of certain pyrazolo(1,5-d)1,2,4-triazines","volume":"28","author":"N A Abdou","year":"1990","journal-title":"Bull Fac Pharm"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0223-5234(02)01445-9","article-title":"Synthesis and investigation of tuberculosis inhibition activities of some 1,2,3-triazole derivatives","volume":"38","author":"K Dabak","year":"2003","journal-title":"Eur J Med Chem"},{"key":"ref5","first-page":"452","article-title":"Synthesis of pyrazole imines and azetidinone compounds using conventional and microwave techniques and studies of their antibacterial activity","volume":"44B","author":"K Mistry","year":"2005","journal-title":"Ind J Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0223-5234(01)01326-5","article-title":"Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds","volume":"37","author":"S G Kucukguzel","year":"2002","journal-title":"Eur J Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.bmc.2005.12.056","volume":"14","author":"G Zoidis","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3797\/scipharm.0912-16","article-title":"Synthesis and Antimicrobial Activity of 3-(1,3,4-Oxadiazol-2-yl)quinazolin-4(3H)-ones","volume":"78","author":"N B Patel","year":"2010","journal-title":"Sci Pharm"},{"key":"ref9","first-page":"485","article-title":"Synthesis, Characterization, Antibacterial and Analgesic evaluation of some 1, 3, 4-Oxadiazole Derivatives","volume":"3","author":"P Jnyanaranjan","year":"2011","journal-title":"Der Pharma Chemica"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0223-5234(96)83976-6","article-title":"Design, synthesis and antiinflammatory activity of some 1,3,4-oxadiazole derivatives","volume":"31","author":"F A Omar","year":"1996","journal-title":"Eur J Med Chem"},{"key":"ref11","first-page":"4419","article-title":"Synthesis and assessment of antitubercular and antimicrobial activity of some novel triazolo and tetrazolo-fused 1, 3, 4-oxadiazole molecules containing pyrazine moiety","volume":"21","author":"R Das","year":"2009","journal-title":"Asian J of Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ardp.200500974","article-title":"Synthesis of some new 2-(6-methoxy-2-naphthyl)- 5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents","volume":"338","author":"B Narayana","year":"2005","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bmcl.2005.02.014","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles","volume":"15","author":"A Zarghi","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0014-827X(02)01245-4","article-title":"Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives","volume":"57","author":"G Sahin","year":"2002","journal-title":"Farmaco"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ejmech.2006.03.002","article-title":"Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl) ethoxy] phenyl]-5-substituted-1,3,4-oxadiazoles","volume":"41","author":"S L Gaonkar","year":"2006","journal-title":"Eur J Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2006.02.007","article-title":"Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents","volume":"71","author":"T M Tan","year":"2006","journal-title":"Antiviral Res"},{"key":"ref17","first-page":"2959","article-title":"Synthesis and in-vitro antioxidant activity of some new 2, 5-disubstituted-1, 3, 4-oxadiazoles containing furan moiety","volume":"2","author":"D K Mehta","year":"2011","journal-title":"Int J of Pharm Sc and Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.bmcl.2007.04.004","article-title":"Oxadiazole mannich bases: Synthesis and antimycobacterial activity","volume":"17","author":"A M Ashraf","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0223-5234(88)90100-6","article-title":"Synthesis and biological evaluation of new C (4) hetero functionalized monocyclic \u03b2-lactams derived from penicillin G","volume":"23","author":"M B Jacqueline","year":"1988","journal-title":"Eur J Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0223-5234(88)90188-2","article-title":"Synthesis and anti-fungal activity of simple \u03b2 lactams","volume":"23","author":"A Arnoldi","year":"1988","journal-title":"Eur J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0223-5234(88)90101-8","article-title":"Measurement of interaction parameters between glutathione and \u03b2-lactam antibiotics: A polarographic approach","volume":"23","author":"JN V Luis","year":"1988","journal-title":"Eur J Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0223-5234(01)01331-9","article-title":"Synthesis and antibacterial activity of dual action agents of a \u03b2-lactum antibiotic with cytotoxic agent mitozolomide or temozolomide","volume":"37","author":"Y Wang","year":"2002","journal-title":"Eur J Med Chem"},{"key":"ref23","first-page":"114","volume-title":"Chemistry and Biology of \u03b2- lactam Antibiotics","author":"K G Holden","year":"1982"},{"key":"ref24","volume-title":"The Organic Chemistry of \u03b2- Lactams","author":"G I George","year":"1993"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/cc020107d","article-title":"An efficient, stereoselective solid-phase synthesis of \u03b2-lactams using mukaiyama\u2019s salt for the staudinger reaction","volume":"5","author":"CM L Delpiccolo","year":"2003","journal-title":"J Comb Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.3.1.13","article-title":"Discovery and development of new antimicrobial agents","volume":"3","author":"T D Gootz","year":"1990","journal-title":"Clin Microbiol Rev Clin Microbiol Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/7081_011","article-title":"Overcoming bacterial resistance: role of \u03b2-lactamase inhibitors","volume":"2","author":"S N Maiti","year":"2006","journal-title":"Top Heterocycl Chem"},{"key":"ref28","first-page":"69","article-title":"Beta-lactams in the new millennium. Part-1: monobactams and carbapenems. Mini Rev Med","volume":"4","author":"G S Singh","year":"2004","journal-title":"Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1016\/S0040-4020(03)01099-8","article-title":"Recent progress in the synthesis and chemistry of azetidinones","volume":"59","author":"G S Singh","year":"2003","journal-title":"Tetrahedro"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1016\/S0040-4020(01)01036-5","article-title":"A new simple route for the synthesis of (\u00b1)-2- azetidinones starting from \u03b2-enaminoketoesters","volume":"57","author":"C D Risi","year":"2001","journal-title":"Tetrahedron"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.arabjc.2010.07.005","article-title":"Synthesis and antimicrobial activity of schiff base and 2-azetidinones derived from quinazoline-4(3H)-one","volume":"4","author":"B P Navin","year":"2011","journal-title":"Arabian Journal of Chemistry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4314\/tjpr.v10i2.66567","article-title":"Synthesis and antitubercular activities of some novel trihydroxy benzamido azetidin-2-one derivatives","volume":"10","author":"K Ilango","year":"2011","journal-title":"Tropical Journal of Pharmaceutical Research"},{"key":"ref33","first-page":"773","article-title":"Synthesis of pyrimidine based azetidinones and thiazolidinones: Antimicrobial and antitubercular agent","volume":"45B","author":"R B Patel","year":"2006","journal-title":"Indian Journal of Chemistry"},{"key":"ref34","first-page":"S358","article-title":"Synthesis and investigation of antioxidant and antimicrobial activity of 3-nitro-N-(3-Chloro-2-oxosubstituted-phenyl-azetidin-1-yl) naphtho [2,1-b]furan-2-carboxamide","volume":"7","author":"V P Vaidya","year":"2010","journal-title":"Eur J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/jm00038a001","article-title":"2-Azetidinones as inhibitors of cholesterol absorption","volume":"37","author":"D A Burnett","year":"1994","journal-title":"J Med Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.bmc.2006.12.031","article-title":"Azetidinones as vasopressin V1a antagonists","volume":"15","author":"G A Koppel","year":"2007","journal-title":"Bio Org Med Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/jm00085a007","article-title":"Antimycobacterial activity of a series of pyrazinoic acid esters","volume":"35","author":"M H Cynamon","year":"1992","journal-title":"J Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/AAC.39.9.2088","article-title":"In vitro antimycobacterial activities of pyrazinamide analogs","volume":"39","author":"S Yamamoto","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-827X(01)01187-9","article-title":"Ring substituted 3-phenyl-1-(2pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents","volume":"57","author":"V Opletalova","year":"2002","journal-title":"II Farmaco"},{"key":"ref40","first-page":"193","article-title":"Studies on pyrazine derivatives XXII Synthesis and tuberculostatic activity of the products of reactions of pyrazinyl-1, 3, 4-oxadiazol-2-thione with amines","volume":"45","author":"D Pancechowska-Ksepko","year":"1988","journal-title":"Acta Pol Pharm"},{"key":"ref41","first-page":"523","article-title":"Studies of pyrazine derivatives. XXI.Synthesis and tuberculostatic activity of 4-aryl-1pyrazinoylthiosemicarbazides and the products of their cyclization to 1, 2, 4-triazole3-thione derivatives","volume":"43","author":"W Rudnicka","year":"1986","journal-title":"Acta Pol Pharm"},{"key":"ref42","first-page":"347","article-title":"Novel coumarinyl-oxadiazolyl-azetidinone & thiazolidinone derivatives: design, synthesis and antimicrobial activity","volume":"4","author":"D Ronak","year":"2018","journal-title":"RJLBPCS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.bmcl.2016.09.059","article-title":"1H-1,2,3-Triazolyl-substituted 1,3,4-oxadiazole derivatives containing structural features of ibuprofen\/naproxen: Their synthesis and antibacterial evaluation","volume":"26","author":"P Neeraja","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jscs.2011.09.005","article-title":"Synthesis, characterization and in vitro antimicrobial screening of quinoline nucleus containing 1,3,4-oxadiazole and 2-azetidinone derivatives","volume":"18","author":"N C Desai","year":"2014","journal-title":"Journal of Saudi Chemical Society"},{"key":"ref45","first-page":"107","article-title":"Synthesis and anti-inflammatory activity of napthylmethyloxadiazoles, thiadiazoles and triazoles","volume":"8","author":"M Amir","year":"1998","journal-title":"Ind J of Het Chem"},{"key":"ref46","volume-title":"Microbiology-A Laboratory Manual","author":"J G Cappucino","year":"1999"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.ejmech.2010.06.031","article-title":"Pharmacological evaluation and characterizations of newly synthesized 1, 2, 4-triazoles","volume":"45","author":"N B Patel","year":"2010","journal-title":"Eur. J Med Chem"},{"key":"ref49","first-page":"1","year":"2010","journal-title":"Tutorial"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/j.1742-4658.2006.05481.x","article-title":"Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis","volume":"273","author":"E Morgunova","year":"2006","journal-title":"FEBS J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1021\/bi047848a","article-title":"Crystal structure of Lumazine synthase from mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors","volume":"44","author":"E Morgunova","year":"2005","journal-title":"Biochemistry"}],"container-title":["Drug Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1252-2378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T19:14:32Z","timestamp":1608664472000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1252-2378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":50,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1252-2378","relation":{},"ISSN":["2194-9379","2194-9387"],"issn-type":[{"value":"2194-9379","type":"print"},{"value":"2194-9387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]}}}